INTERNATIONAL PHARMACEUTICAL QUALITY
Inside the Global Regulatory Dialogue

The News In Depth

COVID-19 Vaccine Urgency Throws Spotlight on Next-Gen Sequencing as Key Facilitator

The urgency of delivering a vaccine for COVID-19 in previously unattainable timeframes and volumes is throwing the spotlight on the expanded role next-generation sequencing (NGS) needs to play to avoid the time delays and other limitations of in vivo/animal testing.

PART II: Sanofi Pasteur and Ghent University Experience with NGS [CLICK HERE]

PART III: A Decade of Regulator/Industry Collaboration on NGS [CLICK HERE]

PART IV: Stakeholder Engagement Begins on ICH Q5A Revision [CLICK HERE]

PART V: Effort to Reduce Animal Testing for Vaccines Includes Global Health Fund Support for NGS [CLICK HERE]

Read More News in Depth

Upcoming Global Dialogue

IPQ’s virtual meeting schedule through July includes:

 

IPQ would like to thank our sponsors: